STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
Covered by 2 sources from United States. First reported by STAT ·
How 2 newspapers cover this story
STAT+: FDA warns GLP-1 drugs carry potential risk of rare eye condition
The FDA on Monday warned that GLP-1 drugs carry a potential risk for a rare but serious eye condition that's sometimes referred to as an "eye stroke."
FDA orders new warning on GLP-1s over rare eye condition linked to sudden blindness
The Food and Drug Administration said Monday that GLP-1 drugmakers must add a warning label about a rare eye condition that can cause sudden blindness.
Coverage details
2 outlets from United States are covering this story: STAT and NBC News. STAT published it first, on November 9, 2026; the last outlet to join was NBC News, 2 hours later.
